Literature DB >> 10671477

Stimulation of slow skeletal muscle fiber gene expression by calcineurin in vivo.

F J Naya1, B Mercer, J Shelton, J A Richardson, R S Williams, E N Olson.   

Abstract

Adult skeletal muscle fibers can be categorized into fast and slow twitch subtypes based on specialized contractile and metabolic properties and on distinctive patterns of muscle gene expression. Muscle fiber-type characteristics are dependent on the frequency of motor nerve stimulation and are thought to be controlled by calcium-dependent signaling. The calcium, calmodulin-dependent protein phosphatase, calcineurin, stimulates slow fiber-specific gene promoters in cultured skeletal muscle cells, and the calcineurin inhibitor, cyclosporin A, inhibits slow fiber gene expression in vivo, suggesting a key role of calcineurin in activation of the slow muscle fiber phenotype. Calcineurin has also been shown to induce hypertrophy of cardiac muscle and to mediate the hypertrophic effects of insulin-like growth factor-1 on skeletal myocytes in vitro. To determine whether activated calcineurin was sufficient to induce slow fiber gene expression and hypertrophy in adult skeletal muscle in vivo, we created transgenic mice that expressed activated calcineurin under control of the muscle creatine kinase enhancer. These mice exhibited an increase in slow muscle fibers, but no evidence for skeletal muscle hypertrophy. These results demonstrate that calcineurin activation is sufficient to induce the slow fiber gene regulatory program in vivo and suggest that additional signals are required for skeletal muscle hypertrophy.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10671477     DOI: 10.1074/jbc.275.7.4545

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  140 in total

1.  MEF2 responds to multiple calcium-regulated signals in the control of skeletal muscle fiber type.

Authors:  H Wu; F J Naya; T A McKinsey; B Mercer; J M Shelton; E R Chin; A R Simard; R N Michel; R Bassel-Duby; E N Olson; R S Williams
Journal:  EMBO J       Date:  2000-05-02       Impact factor: 11.598

2.  Activation of MEF2 by muscle activity is mediated through a calcineurin-dependent pathway.

Authors:  H Wu; B Rothermel; S Kanatous; P Rosenberg; F J Naya; J M Shelton; K A Hutcheson; J M DiMaio; E N Olson; R Bassel-Duby; R S Williams
Journal:  EMBO J       Date:  2001-11-15       Impact factor: 11.598

3.  Differential localization of HDAC4 orchestrates muscle differentiation.

Authors:  E A Miska; E Langley; D Wolf; C Karlsson; J Pines; T Kouzarides
Journal:  Nucleic Acids Res       Date:  2001-08-15       Impact factor: 16.971

4.  Regulation of myosin heavy chain expression during rat skeletal muscle development in vitro.

Authors:  C E Torgan; M P Daniels
Journal:  Mol Biol Cell       Date:  2001-05       Impact factor: 4.138

5.  Calcineurin regulates slow myosin, but not fast myosin or metabolic enzymes, during fast-to-slow transformation in rabbit skeletal muscle cell culture.

Authors:  J D Meissner; G Gros; R J Scheibe; M Scholz; H P Kubis
Journal:  J Physiol       Date:  2001-05-15       Impact factor: 5.182

6.  A calcineurin-NFATc3-dependent pathway regulates skeletal muscle differentiation and slow myosin heavy-chain expression.

Authors:  U Delling; J Tureckova; H W Lim; L J De Windt; P Rotwein; J D Molkentin
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

7.  Dual roles of modulatory calcineurin-interacting protein 1 in cardiac hypertrophy.

Authors:  Rick B Vega; Beverly A Rothermel; Carla J Weinheimer; Atilla Kovacs; R H Naseem; Rhonda Bassel-Duby; R S Williams; Eric N Olson
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-06       Impact factor: 11.205

8.  Impaired myogenesis in estrogen-related receptor γ (ERRγ)-deficient skeletal myocytes due to oxidative stress.

Authors:  Jennifer Murray; Johan Auwerx; Janice M Huss
Journal:  FASEB J       Date:  2012-10-04       Impact factor: 5.191

9.  Conditional activation of akt in adult skeletal muscle induces rapid hypertrophy.

Authors:  Ka-Man V Lai; Michael Gonzalez; William T Poueymirou; William O Kline; Erqian Na; Elizabeth Zlotchenko; Trevor N Stitt; Aris N Economides; George D Yancopoulos; David J Glass
Journal:  Mol Cell Biol       Date:  2004-11       Impact factor: 4.272

10.  Extracellular superoxide dismutase ameliorates skeletal muscle abnormalities, cachexia, and exercise intolerance in mice with congestive heart failure.

Authors:  Mitsuharu Okutsu; Jarrod A Call; Vitor A Lira; Mei Zhang; Jean A Donet; Brent A French; Kyle S Martin; Shayn M Peirce-Cottler; Christopher M Rembold; Brian H Annex; Zhen Yan
Journal:  Circ Heart Fail       Date:  2014-02-12       Impact factor: 8.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.